Elekta AB (publ) (OTCMKTS:EKTAY) Raised to “Hold” at Sanford C. Bernstein

Elekta AB (publ) (OTCMKTS:EKTAY) was upgraded by Sanford C. Bernstein from a “strong sell” rating to a “hold” rating in a research note issued to investors on Wednesday,Zacks.com reports.

Elekta AB (publ) Stock Performance

Shares of Elekta AB (publ) stock opened at $5.99 on Wednesday. The business has a 50-day moving average of $5.63 and a 200 day moving average of $6.11. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.05 and a quick ratio of 0.81. Elekta AB has a 12 month low of $5.25 and a 12 month high of $8.24. The stock has a market capitalization of $2.30 billion, a price-to-earnings ratio of 23.94 and a beta of 1.22.

Elekta AB (publ) (OTCMKTS:EKTAY) last posted its quarterly earnings results on Wednesday, November 27th. The company reported $0.06 EPS for the quarter. Elekta AB (publ) had a net margin of 5.65% and a return on equity of 11.07%. As a group, sell-side analysts forecast that Elekta AB will post 0.36 earnings per share for the current year.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.